Critchlow S E, O'Dea M H, Howells A J, Couturier M, Gellert M, Maxwell A
Department of Biochemistry, University of Leicester, Leicester, LE1 7RH, UK.
J Mol Biol. 1997 Nov 7;273(4):826-39. doi: 10.1006/jmbi.1997.1357.
We have studied the interaction of the F plasmid killer protein CcdB with its intracellular target DNA gyrase. We confirm that CcdB can induce DNA cleavage by gyrase and show that this cleavage reaction requires ATP hydrolysis when the substrate is linear DNA, but is independent of hydrolysis when negatively supercoiled DNA is used. The 64 kDa domain of the gyrase A protein, which can catalyse DNA cleavage in the presence of the B protein and quinolone drugs, is unable to cleave DNA in the presence of CcdB unless the C-terminal 33 kDa domain of the gyrase A protein is also present. CcdB-induced DNA cleavage by gyrase requires a minimum length of DNA (> approximately 160 bp), whereas in the presence of quinolone drugs gyrase can cleave much shorter DNA molecules. We show that CcdB, like quinolones, can form a complex with gyrase which can block transcription by RNA polymerase. A model for the interaction of CcdB with gyrase involving the trapping of a post-strand-passage intermediate is suggested. We conclude that CcdB can stabilise a cleavage complex between DNA gyrase and DNA in a manner distinct from quinolones but, like the quinolone-induced cleavage complex, the CcdB-stabilised complex can also form a barrier to the passage of polymerases.
我们研究了F质粒杀伤蛋白CcdB与其细胞内靶标DNA促旋酶的相互作用。我们证实CcdB可诱导促旋酶切割DNA,并表明当底物为线性DNA时,这种切割反应需要ATP水解,但当使用负超螺旋DNA时则与水解无关。促旋酶A蛋白的64 kDa结构域,在B蛋白和喹诺酮类药物存在时可催化DNA切割,但在CcdB存在时无法切割DNA,除非促旋酶A蛋白的C末端33 kDa结构域也存在。CcdB诱导促旋酶切割DNA需要至少一定长度的DNA(>约160 bp),而在喹诺酮类药物存在时,促旋酶可切割更短的DNA分子。我们表明,CcdB与喹诺酮类药物一样,可与促旋酶形成复合物,该复合物可阻断RNA聚合酶的转录。提出了一个CcdB与促旋酶相互作用的模型,该模型涉及捕获链通过后的中间体。我们得出结论,CcdB可以以一种不同于喹诺酮类药物的方式稳定DNA促旋酶与DNA之间的切割复合物,但是,与喹诺酮类药物诱导的切割复合物一样,CcdB稳定的复合物也可以对聚合酶的通过形成障碍。